0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Giant Primary Melanoma With No Apparent Metastases: A Report of 2 Cases FREE

Tracie Ann Chong, BA1; Lauren Strazzula, BA2; Mai P. Hoang, MD2,3; Ryan Arakaki, BS3; Daniela Kroshinsky, MD, MPH3
[+] Author Affiliations
1School of Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu
2Massachusetts General Hospital, Boston
3Harvard Medical School, Massachusetts General Hospital, Boston
JAMA Dermatol. 2014;150(5):574-575. doi:10.1001/jamadermatol.2013.6892.
Text Size: A A A
Published online

Large primary cutaneous melanomas convey an ominous risk of metastases. The finding of large-scale melanomas without regional or distant metastases suggests a less aggressive biology for this type of tumor.

REPORT OF CASES

Case 1

A man in his 60s presented with a 2-year history of a bleeding mass on his left thigh. Examination revealed a 6.0 × 8.2-cm fungating tumor with a 4-mm palpable left inguinal node. The patient underwent wide excision with clear margins. Histologic examination of the excision revealed an expansile proliferation of epithelioid neoplastic cells with abundant cytoplasm and prominent nucleoli. The tumor extended into the subcutaneous tissue to a depth of 6 cm. The tumor cells were positive for Mart-1 and S-100 immunostains. An in situ component and ulceration were identified. Five mitoses/mm2 were identified, and there was no evidence of lymphovascular invasion. Fine-needle aspiration biopsy of the enlarged lymph node identified no malignant cells. One sentinel lymph node in the left inguinal region was negative for metastasis, and whole-body positron emission tomography (PET)/computed tomography (CT) scan showed no evidence for metastatic disease. He declined chemotherapy and was disease free at last follow-up, 4 years after diagnosis.

Case 2

A man in his 60s presented with a 1-year history of an 8 × 7-cm tumor on his left back associated with fever and left axillary lymphadenopathy (Figure). Histologic sections of the surgical resection revealed a nodular proliferation of atypical and epithelioid melanocytes that extended into the reticular dermis to a depth of 2.4 cm. Sixteen mitoses/mm2 were identified, and the margins were negative. Two sentinel lymph nodes in the left axilla were negative for metastasis by S-100 and Mart-1 immunostains. A chest, abdomen, and pelvis CT scan and subsequent whole-body PET scan were negative for metastatic disease. The patient died 4 months after diagnosis due to chronic cardiac disease.

Place holder to copy figure label and caption
Figure.
Primary Giant Melanoma Lesion

An 8 × 7-cm erythematous eroded mass was noted on the back of patient 2.

Graphic Jump Location

DISCUSSION

Cases of giant primary melanoma, defined as lesions at least 10 cm in diameter1 or 48 mm in thickness,2 are almost exclusively associated with extensive metastatic disease.1 To our knowledge, only 2 other cases of giant primary melanoma without extensive metastasis have been described in the literature.3,4

Studies have illustrated that certain primary melanoma subtypes are associated with favorable prognostic outcomes. Desmoplastic melanoma is a rare variant with variable presentation that is marked histologically by fusiform melanocytes in a sclerotic stroma.5 Investigators have found that patients with pure desmoplastic melanoma (desmoplasia found throughout the tumor) have a more advanced Breslow depth and less regional metastasis than patients with conventional melanoma.5 Primary dermal melanoma, a more recently described variant that is confined to the dermis and may histologically resemble cutaneous metastasis, also appears to have improved survival compared with metastatic melanoma or primary nodular melanoma of equal Breslow thickness.6

These cases challenge the current belief that large primary cutaneous melanoma of long duration connotes extensive metastatic disease and/or rapid death. Although our conclusions are somewhat limited by the inability to assess long-term outcomes in patient 2, both patients reported a prolonged duration of symptoms and had negative findings on metastatic workup, suggesting a less aggressive biology for these tumors. With the discovery of various genetic mutations in primary melanomas, there has been a recent movement to reclassify melanoma subtypes based on genetic profile, which may predict pathologic behavior and therefore outcome more accurately than histopathologic features. We propose that these cases may represent a distinct genetic subtype of giant melanoma that, while locally aggressive, lacks propensity for metastasis.

ARTICLE INFORMATION

Corresponding Author: Daniela Kroshinsky, MD, MPH, Harvard Medical School, Massachusetts General Hospital, 50 Staniford St, Ste 200, Boston, MA 02114 (dkroshinsky@partners.org).

Published Online: January 29, 2014. doi:10.1001/jamadermatol.2013.6892.

Conflict of Interest Disclosures: None reported.

Additional Contributions: We are indebted to Greg Sakamoto, MD, for his help with the diagnosis and management of these interesting cases.

REFERENCES

Ching  JA, Gould  L.  Giant scalp melanoma: a case report and review of the literature. Eplasty. 2012;12:e51.
PubMed
Kruijff  S, Vink  R, Klaase  J.  Salvage surgery for a giant melanoma on the back. Rare Tumors. 2011;3(3):e28.
PubMed   |  Link to Article
Harting  M, Tarrant  W, Kovitz  CA, Rosen  T, Harting  MT, Souchon  E.  Massive nodular melanoma: a case report. Dermatol Online J. 2007;13(2):7.
PubMed
Panajotovic  L, Dordevic  B, Pavlovic  MD.  A giant primary cutaneous melanoma of the scalp--can it be that big? J Eur Acad Dermatol Venereol. 2007;21(10):1417-1418.
PubMed   |  Link to Article
Chen  LL, Jaimes  N, Barker  CA, Busam  KJ, Marghoob  AA.  Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68(5):825-833.
PubMed   |  Link to Article
Cassarino  DS, Cabral  ES, Kartha  RV, Swetter  SM.  Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol. 2008;144(1):49-56.
PubMed

Figures

Place holder to copy figure label and caption
Figure.
Primary Giant Melanoma Lesion

An 8 × 7-cm erythematous eroded mass was noted on the back of patient 2.

Graphic Jump Location

Tables

References

Ching  JA, Gould  L.  Giant scalp melanoma: a case report and review of the literature. Eplasty. 2012;12:e51.
PubMed
Kruijff  S, Vink  R, Klaase  J.  Salvage surgery for a giant melanoma on the back. Rare Tumors. 2011;3(3):e28.
PubMed   |  Link to Article
Harting  M, Tarrant  W, Kovitz  CA, Rosen  T, Harting  MT, Souchon  E.  Massive nodular melanoma: a case report. Dermatol Online J. 2007;13(2):7.
PubMed
Panajotovic  L, Dordevic  B, Pavlovic  MD.  A giant primary cutaneous melanoma of the scalp--can it be that big? J Eur Acad Dermatol Venereol. 2007;21(10):1417-1418.
PubMed   |  Link to Article
Chen  LL, Jaimes  N, Barker  CA, Busam  KJ, Marghoob  AA.  Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68(5):825-833.
PubMed   |  Link to Article
Cassarino  DS, Cabral  ES, Kartha  RV, Swetter  SM.  Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol. 2008;144(1):49-56.
PubMed

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

544 Views
0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Melanoma

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Melanoma

×